Evidence map›Paper›PMID 41474815›Full record

ArticlePloS one2025

DualMask: Federated optimization of privacy-utility-efficiency trilemma via orthogonal gradient perturbation and RL-optimized PSO.

Weibai Zhou, Changlong Li, Rong Li, Dan Huang

Abstract read
In one paragraph

Article in PloS one, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Weibai ZhouSchool of Information Technology and Engineering, Guangzhou College of Commerce, Guangzhou, Guangdong, China.ORCID 0009-0009-6291-4362
Changlong LiSchool of Information Technology and Engineering, Guangzhou College of Commerce, Guangzhou, Guangdong, China.
Rong LiSchool of Information Technology and Engineering, Guangzhou College of Commerce, Guangzhou, Guangdong, China.
Dan HuangSchool of Information Technology and Engineering, Guangzhou College of Commerce, Guangzhou, Guangdong, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Federated learning faces a fundamental privacy-utility-communication trilemma, and existing static defense mechanisms suffer from rigid adaptation and poor multidimensional coordination, leaving a critical gap in dynamic trade-off balancing. To address this, we propose DualMask, a cooperative optimization framework that integrates a client-side Adaptive Orthogonal Noise Canceler (AONC) with server-side Distributed Dueling Double Deep Q-Network (D3QN) scheduling and Particle Swarm Optimization (PSO)-based aggregation. The AONC module implements a triple-defense mechanism via orthogonal subspace projection: (1) layer-wise adaptive EMA-quantile clipping to mitigate threshold imbalance, (2) progress-aware noise decay that balances early-stage privacy with late-stage efficiency, and (3) directional tuning that dynamically adjusts parallel-to-orthogonal gradient ratios. On the server side, D3QN enables dynamic resource allocation across heterogeneous devices, while PSO fusion corrects non-IID aggregation bias through particle-swarm-based weight optimization. Experiments on CIFAR-10/100 and Shakespeare datasets demonstrate that DualMask achieves 5.2% higher accuracy (84.1% vs 79.4% in non-IID settings) and 34.4% faster convergence (210 vs 320 rounds) compared to FedAvg. Additionally, DualMask reduces the privacy budget [Formula: see text] from 4.5 to 2.8 and communication cost by 37.2% (45 MB vs 65 MB). This constitutes a significant Pareto improvement, substantially expanding the trilemma frontier. The code and data are available at https://github.com/zhou-weib/DualMask.git.

Indexed as

PrivacyAlgorithmsHumans

Identifiers

PMID41474815
PMCPMC12755795

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.